NGNE — Neurogene Inc. stock price, charts and financials

QT84Neurogene Inc.

Neurogene Inc. (NASDAQ: NGNE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
32.09
-0.32-0.99%
OverviewShort InterestFilings
NGNEQT84Neurogene Inc.·NASDAQ
32.09-0.99%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 2026424B5Prospectus
Jun 30, 2026424B5Prospectus
Jun 29, 20268-KCurrent report
Jun 16, 20263/AInitial statement of beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 08, 20268-KCurrent report
Jun 04, 20268-KCurrent report
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 08, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
Apr 20, 20263Initial statement of beneficial ownership
Apr 20, 20268-KCurrent report
Apr 16, 2026ARSAnnual report to shareholders
Apr 16, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 145
Page
▼
/ 6